Home NDC 50090-1244-0 Tamiflu
Product NDC 50090-1244
Requested package NDC 50090-1244-0
11-digit product format 500901244
Labeler code 50090
Product ID 50090-1244_722685dc-b97a-4978-98d2-91b2afd3907b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Oseltamivir Phosphate
Dosage form POWDER, FOR SUSPENSION
Route ORAL
Labeler A-S Medication Solutions
Application NDA021246
Marketing category NDA
Marketing start 2011-03-21
Marketing end 0000-00-00
Substance OSELTAMIVIR PHOSPHATE
Active strength 6 mg/mL
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021246-001 TAMIFLU OSELTAMIVIR PHOSPHATE EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 N021246-002 TAMIFLU OSELTAMIVIR PHOSPHATE EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021246-002 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021246-001 TAMIFLU EQ 12MG BASE/ML FOR SUSPENSION / ORAL 2000-12-14 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021246-002 TAMIFLU EQ 6MG BASE/ML FOR SUSPENSION / ORAL AB RLD, RS 2011-03-21 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Observed Orange Book exclusivity history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-1244-0 Tamiflu 60 mL in 1 BOTTLE, GLASS POWDER, FOR SUSPENSION 60 8 50090-1244-0 Tamiflu 1 in 1 CARTON POWDER, FOR SUSPENSION 1 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-1244 TAMIFLU (OSELTAMIVIR PHOSPHATE) POWDER, FOR SUSPENSION [A-S MEDICATION SOLUTIONS] 8 Legacy NDC, 2 package rows 20210223_247fb507-b3a1-4005-abb9-d17774fa2996.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Tamiflu OSELTAMIVIR PHOSPHATE Genentech, Inc. ee3c9555-60f2-4f82-a760-11983c86e97b 2025-12-15 Warnings, Adverse reactions Exact identifier application applno (NDA): 021246 application number: NDA021246
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 50090-1244-0 50090124400 1 BOTTLE, GLASS in 1 CARTON (50090-1244-0) > 60 mL in 1 BOTTLE, GLASS 2014-11-28 0000-00-00 No No Current